Maine's Prescription Monitoring Program
Effective July 1, 2018
Dear Prescription Data Submitter,
The PMP Clearinghouse has been updated to the ASAP version 4.2A. This update includes the functionality to capture exemption codes for opioid prescriptions exceeding 100 morphine milligram equivalents, and the ICD-10 codes for the palliative care exemption.
The updated user guide outlining the ASAP 4.2A specifications, as well as a guide that crosswalks the Maine exemption codes to the ASAP 4.2A Treatment Codes is available on the Maine PMP website and is available in the Quick Links section of your PMP dashboard.
IMPORTANT CHANGES TO NOTE:
• DSP05 – Date Filled
This field should reflect the date the prescription left the pharmacy. This is to ensure that the patient report accurately reflects the date the patient received the prescription.
• DSP24 – Treatment Type
Required for opioid prescriptions exceeding 100 MME (see attached guide/crosswalk)
• DSP25 – Diagnosis Code
Required when Palliative Care Exemption Code is utilized for opioid prescriptions exceeding 100 MME
You may begin reporting in ASAP 4.2A now, as the system will be accepting both ASAP 4.2 and ASAP 4.2A.
Effective July 1, 2018, the system will only accept ASAP 4.2A. (14-118 C.M.R. ch. 11, §5(C, 1, n.))
For additional information, please contact the PMP Team at SAMHS.PMP@maine.gov or by phone at (207) 287-2595 option 2.
For technical assistance, please contact the Appriss Clearinghouse helpdesk at (844) 463-4767
Thank you for your continued help preventing prescription drug misuse, abuse and diversion.
The Prescription Monitoring Program Team
June 1, 2018: Data Submission Dispenser Guide (PDF)
Septermber 5, 2017: Integrate Maine’s PMP with your EHR or Pharmacy Management System (PDF)
July 28, 2017: Opioid Dispensing Clarifications (PDF)
July 28, 2017: Electronic Prescribing Clarifications (PDF)
June 30, 2017: LD 1363 Resolve, Regarding Legislative Review of Portions of Chapter 11: Rules Governing the Controlled Substances Prescription Monitoring Program and Prescription of Opioid Medications, a Late-filed Major Substantive Rule of the Department of Health and Human Services
June 29, 2017: Dear Prescribers, Dispensers, Professional Boards and Societies, and other interested parties:
The Maine Department of Health and Human Services would like to thank you for your commitment to the people of Maine. Under Public Law Chapter 488, An Act to Prevent Opioid Abuse by Strengthening the Controlled Substances Prescription Monitoring Program (PMP), electronic prescribing becomes mandatory on July, 1, 2017 or individuals would face a penalty. Read More (*PDF)
April 3rd, 2017: E-Prescribing Waiver Applications are now available. SAMHS will begin accepting waiver applications on Monday April 3rd. View E-Prescribing Page
March 31, 2017:In an effort to combat the Maine opioid epidemic, the Maine Legislature enacted P.L. 2015, ch. 488 (An Act to Prevent Opiate Abuse by Strengthening the Controlled Substances Prescription Monitoring Program). P.L. 2015, ch. 488 to amend the Prescription Monitoring Program (PMP)(Title 22, Chapter 1603) to include prescriber limits on opioid medication prescribing, effective January 1, 2017; included veterinarians in the definition of prescribers; required electronic prescribing and required prescribers and dispensers to check the Prescription Monitoring Program (PMP) database. Ch. 488 required the Department to establish reasonable exceptions to prescriber limits, and ordered the Department to include prescribers in the process of drafting appropriate exceptions and in the drafting of draft rules. With the guidance of the Maine State Health Officer Dr. Christopher Pezzullo, the Department convened a PMP Stakeholder Group that included the Maine Medical Association, the Maine Hospital Association, the Maine Physician Assistant Association, the Maine Nurse Practitioners Association, the Maine Veterinary Medical Association, the Maine Pharmacy Association, and the Maine Osteopathic Association. SAMHS Rules | PDF
January 23, 2017: Notice of Agency Rule-making Proposal for 14-118 C.M.R. Chapter 11, Rules Governing the Controlled Substances Prescription Monitoring Program and Prescription of Opioid Medications. Read More…
Effective July 29, 2016: Implementation of Chapter 488 Public Law: An Act to Prevent Opiate Abuse by Strengthening the Controlled Substances Prescription Monitoring Program Read More | View Public Law, Chapter 488
Registration for the PMP Web Portal:
Submit Your Questions:
You may access the Maine PMP at https://maine.pmpaware.net/login.
The Maine PMP AWARxE User Support Manual includes guidance for running patient and prescriber reports in the PMP system. For further technical assistance with logging in or running reports, you can contact the Appriss help desk at 1-844-4ME-4PMP (1-844-463-4767).
The Prescription Monitoring Program (PMP) is a secure online database that is used across the State of Maine to improve public health. All prescribers and dispensers are able to review their patient’s controlled substance drug history prior to prescribing or dispensing any schedule II – IV drugs. All prescribers and dispensers are able to be connected to this centralized system. The PMP helps to prevent adverse drug-related events through opioid overdoses, drug diversion, and substance abuse by decreasing the amount and/or frequency of opioid prescribing.
AGENCY CONTACT PERSON: Johanna Buzzell, Prescription Monitoring Program Coordinator , DHHS / SAMHS, 41 Anthony Avenue, 11 State House Station, Augusta, ME 04333. Telephone: (207) 287-2595.
Documents in PDF format require the free Adobe Acrobat Reader to view them.